Epigenetics is driving discoveries in the treatment and understanding of hematological diseases. EpiCypher is a world-leading developer of innovative research products and services to advance the science of epigenetic regulation and improve human health. From genomic mapping to high-throughput drug screening, our CUTANA™ CUT&RUN/CUT&Tag and comprehensive class of nucleosome substrates and enzymes provide the tools you need to take your project to the next level.